Skip to main content

Latest stock market podcasts

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Grady Wulff
November 8, 2022
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Morning Bell 11 September

Bell Direct
September 11, 2025

Morning Bell 10 September

Bell Direct
September 10, 2025

Morning Bell 9 September

Bell Direct
September 9, 2025

Morning Bell 8 September

Bell Direct
September 8, 2025

Weekly Wrap 5 September

Bell Direct
September 5, 2025

Morning Bell 4 September

Bell Direct
September 4, 2025

Morning Bell 3 September

Bell Direct
September 3, 2025

Morning Bell 2 September

Bell Direct
September 2, 2025

Morning Bell 1 September

Bell Direct
September 1, 2025

Weekly Wrap 29 August

Bell Direct
August 29, 2025

Morning Bell 28 August

Bell Direct
August 28, 2025

Reporting Season August 2025 – Week 4

Bell Direct
August 27, 2025